The fight against blindness-causing trachoma received a boost on Thursday following the launch of a cross-border mass drug administration exercise by Kenya and Uganda.
The exercise, which was launched at Alakas Primary School in Amudat district of Uganda, seeks to synchronise drug administration among the residents of West Pokot and Turkana Counties with neighbouring Uganda in an effort to fully eradicate the disease which is caused by bacteria that attack the inner surfaces of the eyelids.
Speaking during the launch of the exercise, Ugandan State Minister for Karamoja affairs Dr Maria Goretti welcomed the latest initiative saying it will ensure that communities living along the common Kenya-Uganda border receive the much-needed treatment. Goretti said previous efforts where respective governments conducted mass drug administration at different times saw a section of the local community miss out as they are largely pastoralists who move across the two nations in search of pasture.
Speaking at the same event, Head division of vector borne and neglected tropical diseases at the ministry of health Wycliffe Omondi said there was need to employ a multi-faceted approach in the fight against the disease if the region is to comprehensively deal with the trachoma challenge. “Mass drug administration on its own is not the silver bullet. We must put in place collaborative mechanisms to ensure that prevalence remains where treatment has taken it to.” He observed.
According to Dr. Teshome Gebre Kanno, International Trachoma initiative regional director for Africa, regional governments must give the disease the required attention through collaborative approach devoid of political boundaries. Sentiments echoed by West Pokot County chief executive officer in charge of health and sanitation Christine Apokoreng who said such synchronised and coordinated efforts will guarantee maximum results.
This year (2021) the National Trachoma elimination program targets to treat 2,826,638 persons across seven counties of Baringo, Isiolo, Kajiado, Narok, Samburu, Turkana and West Pokot.
Trachoma is listed by the World Health Organization (WHO) as one of the 20 Neglected Tropical Diseases (NTDs) and is the leading infectious cause of blindness globally.
In Kenya, Trachoma is endemic in 12 counties with a combined population of approximately eleven million people. More than 53,200 Kenyans have already been blinded by Trachoma but due to consistent implementation of Mass Drug Administration (MDA) in the country, the situation has recorded tremendous gains.
Since 2007, Kenya has received at least 15 million donations of Zithromax antibiotic from the International Trachoma Initiative (ITI) for use in MDA campaigns with a market value of 30 billion shillings.
Distributed by APO Group on behalf of Ministry of Health, Kenya.
© Press Release 2021
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
